Ovidrel, Ovitrelle (choriogonadotropin alfa) is a protein pharmaceutical. Choriogonadotropin alfa was first approved as Ovidrel on 2000-09-20. It is used to treat cryptorchidism, female infertility, and hypogonadism in the USA. It has been approved in Europe to treat anovulation, assisted reproductive techniques, and female infertility.
|Common Name||Choriogonadotropin alfa|
|Indication||anovulation, assisted reproductive techniques, cryptorchidism, female infertility, hypogonadism|
|Drug Class||Tricyclic compounds; atropine derivatives|